Voprosy meditsinskoi khimii (ISSN 0042-8809)

Effect of docanol on the hemostatic and fibrinolytic systems and lipid spectrum in patients with coronary heart disease in relation to baseline fibrinolytic activity

   
Lyutova L.V., Karabasova M.A., Andreyenko G.V., Panchenko V.M., Isayev V.A., Sorokaletov S.M., Yershov A.A.
Type: Clinical study
PubMed Id: 8999661
Year: 1996 vol: 42  issue:1  pages: 64-70
Abstract: Forty patients with coronary heart disease (CHD) concurrent with hyperlipidemia were divided into 2 groups according to the baseline fibrinolytic activity. The group with the depressed fibrinolytic system displayed the highest atherogenicity index and levels of cholesterol, low and very low density lipoprotein cholesterol and half levels of high density lipoproteins. After 45-day ingestion of docanol, a new Russian food additive containing docosahexanoic and eicosapentaenoic acids there were positive changes in the lipid spectrum in the both groups. The fibrinolytic changes were heterodirectional: activator and plasma activities increased in the group of fibrinolytic depression while in the group of baseline normal fibrinolysis the activity of plasminogen activator fell.
Download PDF:
Reference: Lyutova L.V., Karabasova M.A., Andreyenko G.V., Panchenko V.M., Isayev V.A., Sorokaletov S.M., Yershov A.A., Effect of docanol on the hemostatic and fibrinolytic systems and lipid spectrum in patients with coronary heart disease in relation to baseline fibrinolytic activity, Voprosy meditsinskoi khimii, 1996, vol: 42(1), 64-70.
References
 2002(Vol:48)
 2001(Vol:47)
 2000(Vol:46)
 1999(Vol:45)
 1998(Vol:44)
 1997(Vol:43)
 1996(Vol:42)